Previous studies reported that PLK4 was overexpressed in various tumors, including breast cancer [11, 12], lung cancer [13], neuroblastoma [14], colorectal cancer [15], malignant rhabdoid tumors [16], and prostate cancer [17]. Here, PLK4 is linked to breast carcinoma.